Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $644.5100 (1.98%) ($632.7250 - $647.3960) on Mon. Aug. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.54% (three month average) | RSI | 51 | Latest Price | $644.5100(1.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.2% a day on average for past five trading days. | Weekly Trend | REGN declines -0.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) XLV(45%) SPLV(39%) IVW(38%) SPY(37%) | Factors Impacting REGN price | REGN will decline at least -1.27% in a week (0% probabilities). VIXM(-20%) VXX(-7%) UUP(-7%) TBT(-6%) DRIV(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.27% (StdDev 2.54%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $634.17(1.63%) | 10 Day Moving Average | $632.4(1.91%) | 20 Day Moving Average | $634.26(1.62%) | To recent high | -2% | To recent low | 18.9% | Market Cap | $68.337b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |